Methotrexate Injection, Solution
Product Images NDC 62332-712

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 62332-712). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Methotrexate-2ml-carton (Methotrexate 2ml Carton)

This text provides detailed information about a medication called Methotrexate Injection, USP. It includes the contents of each vial, storage instructions, warnings, and manufacturer details. The medication is indicated for intravenous, intramuscular, and subcutaneous use only and should not be used intrathecally. It is a hazardous drug containing a preservative. The text gives guidance on storage temperatures and duration of use after first puncture, along with precautions to protect from light.*

FDA Label Image

Methotrexate-2ml-label (Methotrexate 2ml Label)

This is a description of Methotrexate Injection, which is a hazardous drug with preservatives. It is intended for intravenous, intramuscular, and subcutaneous use. The multiple-dose vial is sterile and contains 25 mg/mL of isotonic liquid. The drug is manufactured by Alembic Pharmaceuticals, Inc. and made in India. The vial has a warning to see the prescribing information for further details. The lot and expiration numbers are not available.*

FDA Label Image

Methotrexate-40ml-carton (Methotrexate 40ml Carton)

This is a product information sheet for Methotrexate Injection, USP (25 mg/mL). The medication is preservative-free and comes in a 40 mL single-dose vial for intravenous, intramuscular, subcutaneous, and intrathecal use only. The text also provides storage instructions and a list of ingredients in the solution. Additionally, it highlights that the drug is hazardous and advises on proper handling and disposal.*

FDA Label Image

Methotrexate-40ml-label (Methotrexate 40ml Label)

This is a product label for Methotrexate Injection, USP with a concentration of 25 mg/ml. It is indicated for intravenous, intramuscular, subcutaneous, and intrathecal use only and is a hazardous drug that is preservative-free. Each vial contains 1000 mg of methotrexate equivalent to 1096.7 mg of methotrexate sodium. The product should be stored at a temperature between 20°C to 25°C (66°F to 77°F) with allowed excursions to 15°C to 30°C (59°F to 86°F). It is important to protect from light. The manufacturer is Alembic Pharmaceuticals, Inc. located in Bedminster, NJ, USA.*

FDA Label Image

Methotrexate-structure (Methotrexate Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.